carlina oxide: isolated from roots of Carlina acaulis L.; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Carlina | genus | [no description available] | Asteraceae | A large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH] |
| Carlina acaulis | species | [no description available] | Asteraceae | A large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH] |
| ID Source | ID |
|---|---|
| PubMed CID | 164634 |
| CHEBI ID | 3420 |
| SCHEMBL ID | 11272511 |
| MeSH ID | M0152929 |
| Synonym |
|---|
| C08399 |
| 502-22-7 |
| carlina oxide |
| furan, 2-(3-phenyl-1-propynyl)- |
| AC1L4V5J , |
| 2-(3-phenylprop-1-ynyl)furan |
| SCHEMBL11272511 |
| AC1Q28AJ , |
| benzyl 2-furylacetylene |
| CHEBI:3420 |
| surecn11272511 |
| AKOS028111351 |
| 2-(3-phenylprop-1-yn-1-yl)furan |
| DTXSID80198237 |
| 2-(3-phenyl-1-propyn-1-yl)furan |
| AS-59276 |
| Q27106067 |
| 2-(3-phenyl-1-propyn-1-yl)-furan;2-(3-phenyl-1-propynyl)-furan |
| EX-A7842K |
Carlina oxide is a compound isolated from Carlina.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Carlina oxide is a compound isolated from" | ( Synthesis of Carlina Oxide Analogues and Evaluation of Their Insecticidal Efficacy and Cytotoxicity. Aguzzi, C; Baldassarri, C; Benelli, G; Cappellacci, L; Ferrati, M; Maggi, F; Palmieri, A; Pavela, R; Petrelli, R; Spinozzi, E; Zeppa, L, 2023) | 2 |
| Class | Description |
|---|---|
| benzenes | Any benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.62) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||